This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Korean Medical Product Maker Ends Bid For Trimeris

DURHAM, N.C. (AP) ¿ Arigene Co., a Korean medical equipment maker, said Tuesday it is terminating its tender offer for outstanding shares of biopharmaceutical company Trimeris Inc.

Arigene couldn't secure enough financing for the offer, the company said.

Trimeris agreed to be acquired on Oct. 2 for about $81 million, or $3.60 per share, and the tender offer was extended until Monday on Nov. 17. Arigene had asked for another extension but Trimeris didn't grant it.

When the offer expired Monday, about 19.3 million, or 86.4 percent of outstanding Trimeris shares, had been tendered. Arigene said the tendered shares will be returned to their holders.

The news sent Trimeris shares down 54 cents, or 17 percent, to $2.64. The stock has traded between 84 cents and $3.68 over the past year.

Copyright 2009 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
AAPL $124.25 -0.14%
FB $81.66 -0.67%
GOOG $542.56 -0.99%
TSLA $187.59 -0.63%
YHOO $44.13 -0.69%


DOW 17,698.18 -77.94 -0.44%
S&P 500 2,059.69 -8.20 -0.40%
NASDAQ 4,880.2280 -20.6570 -0.42%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs